Literature DB >> 19962142

Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.

Yuyan Mao1, Xiaoyun Wan, Yaxia Chen, Weiguo Lv, Xing Xie.   

Abstract

Four of six patients with endometrial cancer had initial response to progesterone therapy and obtained complete response; three among them had successful pregnancies with three live births. The results suggest that progesterone therapy, combined with assisted reproductive technology, provides more chance of carrying a full-term pregnancy for patients with endometrial adenocarcinoma. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19962142     DOI： 10.1016/j.fertnstert.2009.07.999

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  Preserving fertility in young patients with endometrial cancer: current perspectives.

Authors:  Eleftheria Kalogera; Sean C Dowdy; Jamie N Bakkum-Gamez
Journal:  Int J Womens Health       Date:  2014-07-29

Review 2.  Fertility-preservation in endometrial cancer: is it safe? Review of the literature.

Authors:  Márcia Mendonça Carneiro; Rívia Mara Lamaita; Márcia Cristina França Ferreira; Agnaldo Lopes Silva-Filho
Journal:  JBRA Assist Reprod       Date:  2016-12-01

Review 3.  Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.

Authors:  Qing Zhang; Gonghua Qi; Margaux J Kanis; Ruifen Dong; Baoxia Cui; Xingsheng Yang; Beihua Kong
Journal:  Oncotarget       Date:  2017-05-03

4.  Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature.

Authors:  Stéphanie Tock; Pascale Jadoul; Jean-Luc Squifflet; Etienne Marbaix; Jean-François Baurain; Mathieu Luyckx
Journal:  Front Med (Lausanne)       Date:  2018-08-27

5.  Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.

Authors:  Mi Kyoung Kim; Seok Ju Seong; Soon Beom Kang; Duk Soo Bae; Jae Weon Kim; Joo Hyun Nam; Myong Cheol Lim; Taek Sang Lee; Sunghoon Kim; Jiheum Paek
Journal:  J Gynecol Oncol       Date:  2019-01-07       Impact factor: 4.401

6.  Fertility-sparing treatment in women with endometrial cancer.

Authors:  Seyeon Won; Mi Kyoung Kim; Seok Ju Seong
Journal:  Clin Exp Reprod Med       Date:  2020-11-10

7.  Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.

Authors:  Erica Herrera Cappelletti; Jonas Humann; Rafael Torrejón; Pietro Gambadauro
Journal:  Hum Reprod Update       Date:  2022-02-28       Impact factor: 15.610

8.  Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia.

Authors:  Toshiya Matsuzaki; Takeshi Iwasa; Takako Kawakita; Yuri Yamamoto; Akiko Abe; Aki Hayashi; Kiyohito Yano; Masato Nishimura; Akira Kuwahara; Minoru Irahara
Journal:  Reprod Med Biol       Date:  2018-06-01

9.  Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis.

Authors:  Xiao-Li Zhao; Ze-Qing Du; Xuan Zhang; Zhi Yao; Ying-Qiu Liang; Su-Fen Zhao
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.